Literature DB >> 33012829

Left-sided dacryostenosis in a dog.

Jamey Erjavec1.   

Abstract

A 1.5-year-old neutered male black Labrador retriever dog was presented to a referral teaching hospital for evaluation of chronic, continuous, mucoid discharge and associated conjunctivitis of the left eye. Nasolacrimal flush revealed a patent duct on the right side but not on the left side. Computed tomography (CT) with a dacryocystogram identified severe stenosis or atresia of the left nasolacrimal duct. The patient was referred to a veterinary ophthalmologist for a reconstruction of the left nasolacrimal system. Ultimately, a conjunctivobuccostomy was performed and resolved all ocular clinical signs. Key clinical message: Dacryostography, a procedure in which the lacrimal punctum is cannulated, and iodinated contrast is instilled into the nasolacrimal system was combined with CT to enable excellent visualization and evaluation of the nasolacrimal canal. Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.

Entities:  

Mesh:

Year:  2020        PMID: 33012829      PMCID: PMC7488380     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  4 in total

1.  The relief of epiphora by conjunctivorhinostomy.

Authors:  R D Long
Journal:  J Small Anim Pract       Date:  1975-06       Impact factor: 1.522

2.  A new surgical method for the control of the epiphora in dogs: modified parotid duct transposition.

Authors:  S Scotti; A Klein; M Vanore; A Hidalgo; P Fayolle; P Moissonnier
Journal:  J Small Anim Pract       Date:  2007-04-08       Impact factor: 1.522

3.  Canaliculosinostomy as a Long-Term Treatment of Seven Horses for Permanent Obstruction of the Nasolacrimal Duct.

Authors:  Palle Brink; James Schumacher
Journal:  Vet Surg       Date:  2015-11-23       Impact factor: 1.495

4.  Dacryocystomaxillorhinostomy for chronic dacryocystitis in a dog.

Authors:  Elizabeth A Giuliano; Eric R Pope; Erin S Champagne; Cecil P Moore
Journal:  Vet Ophthalmol       Date:  2006 Mar-Apr       Impact factor: 1.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.